FDA’s digital health advisory committee takes shape, and a critique of cost-effectiveness studies
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday.
Jeff Shuren’s FDA legacy: Bringing stability to device regs
The news of Jeff Shuren‘s departure from his long-held role as head of the Food and Drug Administration’s Center for Devices and Radiological Health — which my colleague Lizzy Lawrence reported exclusively last month — has left the medical device world stunned and struggling to imagine the agency without him.
